【摘要】：目的探討非布司他治療慢性痛風性關節(jié)炎及其對NALP3炎性體的影響。方法選取89例慢性痛風性關節(jié)炎患者和50例健康體檢者,檢測各組治療前后NALP3炎性體mRNA及NALP3炎性體的蛋白表達水平。結果治療組治療前血尿酸、NALP3、ASC及Caspase-1 mRNA的表達較對照組高(P0.05)。苯溴馬隆與別嘌醇組治療前后NALP3炎性體無改變。非布司他組治療后血尿酸、NALP3 mRNA(P=0.040)和Caspase-1 mRNA(P=0.023)的表達明顯降低(P0.05),ASC mRNA的表達升高(P=0.043)。非布司他組治療前后比較差異有統(tǒng)計學意義。結論 NALP3炎性體與慢性痛風性關節(jié)炎相關,非布司他可以更好的降尿酸并影響其功能。
[Abstract]:Objective to investigate the effect of non-bustane on chronic gouty arthritis and NALP3 inflammation. Methods 89 patients with chronic gouty arthritis and 50 healthy controls were selected to detect the protein expression of mRNA and NALP3 in NALP3 inflammation body before and after treatment. Results the expression of serum uric acid, NALP3,ASC and Caspase-1 mRNA in the treatment group before treatment was higher than that in the control group (P0.05). There was no change in the inflammatory body of NALP3 before and after treatment in the groups of benzimarone and allopurinol. The expression of serum uric acid, NALP3 mRNA (P < 0. 040) and Caspase-1 mRNA (P < 0. 023) were significantly decreased in non-bustane group after treatment (P < 0. 05). The expression of), ASC mRNA was increased (P < 0. 043). There was significant difference between before and after treatment in non-bustane group. Conclusion NALP3 is associated with chronic gouty arthritis, and non-bustane can reduce uric acid and affect its function.
【作者單位】： 廣州醫(yī)科大學附屬第三醫(yī)院荔灣醫(yī)院風濕科;廣東省醫(yī)學科學院 廣東省人民醫(yī)院風濕科;
【基金】：廣東省科技廳科研基金項目(編號:2016ZC0151)
【分類號】：R589.7

【相似文獻】

相關期刊論文 前10條

1 顏廷立;原發(fā)性痛風性關節(jié)炎78例分析[J];臨床內科雜志;2000年01期

2 錢軼梅,胡學文;痛風性關節(jié)炎7例誤診分析[J];西安醫(yī)科大學學報;2001年01期

3 曹洪國;23例痛風性關節(jié)炎臨床及誤診分析[J];現(xiàn)代醫(yī)藥衛(wèi)生;2001年10期

4 劉愛苓,楊寶旭;痛風性關節(jié)炎的疼痛治療[J];中國冶金工業(yè)醫(yī)學雜志;2005年03期

5 鄭其鳳;常金林;;中西醫(yī)結合治療痛風性關節(jié)炎35例[J];中國民族民間醫(yī)藥;2010年07期

6 喬，

本文編號：2434662